Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease
Abstract Cell transplants are being developed for patients with Parkinson disease (PD) who have insufficient benefit with standard medical treatment. We describe the clinical features of five patients who developed persistent dyskinesias after fetal dopaminergic tissue transplantation. All had levod...
Guardado en:
Autores principales: | Paul E. Greene, Stanley Fahn, David Eidelberg, Kimberly B. Bjugstad, Robert E. Breeze, Curt R. Freed |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/644271643da147bbb1f839328f6c42be |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease
por: Luigi Zecca, et al.
Publicado: (2021) -
Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
por: Bargiotas P, et al.
Publicado: (2013) -
Towards optimising experimental quantification of persistent pain in Parkinson’s disease using psychophysical testing
por: Kirsty Bannister, et al.
Publicado: (2021) -
Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson’s disease
por: Yang X, et al.
Publicado: (2013) -
Genetic and environmental factors in Alzheimer’s and Parkinson’s diseases and promising therapeutic intervention via fecal microbiota transplantation
por: Hui Wang, et al.
Publicado: (2021)